Prathaban elected President at SLCPI 63rd AGM

The Sri Lanka Chamber of Pharmaceutical Industries (SLCPI)  held their 63rd Annual General Meeting recently, with the participation  of its membership including leading pharmaceutical manufacturers and  importers of the country.

Charting its course towards consistent availability of  quality medicine to the Sri Lankan public and sustaining an effective  pharmaceutical industry, the AGM saw the convening of over 230 members  of SLCPI.

Speaking to the collective members as President Elect, M.  Prathaban outlined the challenges that the pharmaceutical industry  experiences during the present economic recovery period, highlighting  the numerous actions taken by SLCPI as a collective body to engage and  advocate for the progress of the pharmaceutical industry in Sri Lanka.

“SLCPI has sustained the pharmaceutical industry of the  country during challenging times in the recent past, and we are  committed to take forward our efforts for the betterment of the  industry,” he emphasised.

“Our innovations and advancements have the power to save  lives, alleviate suffering and enhance the quality of life for millions  of people. As a Chamber, it is our responsibility to put all our  efforts, based on the guidelines of fairness, transparency and  sustainability, to advance our offering to the country,” he added.

SLCPI has actively engaged in advocating for a fair and  transparent pricing mechanism with the end objective of making quality  medicine available to the public. The repeated dialogues with the  regulatory to make quality testing available for import medicines will  continue under the new committee, to ensure high standard medicines are  brought into the market, while maintaining availability and  affordability.

The new board for 2024/25 was appointed with M. Prathaban  Deputy Chairman/Group CEO, Emerchemie NB (Ceylon) Ltd. taking the helm  as President for the second consecutive year. He will be ably supported  by Immediate Past President Sanjiva Wijesekera (Executive Director,  George Steuart Health (Pvt) Ltd.), Senior Vice President Shantha  Bandara (Executive Director/CEO, Sunshine Health Lanka Ltd.), Vice  President Jude Fernando (Managing Director, Hemas Pharmaceuticals (Pvt)  Ltd.), Hon. Secretary Sirimal Fernando (Director/CEO, Astron Limited)  and Hon. Treasurer – Rasika Hirimuthugoda (CEO, Darley Butler & Co  Ltd.).

Council Members elected at the AGM include Indoscan (Pvt)  Ltd, Emar Pharma (Pvt) Ltd, A. Baur & Co. (Pvt) Ltd and Muller &  Phipps Healthcare Ltd.

Astron Ltd. and Emergen Lifescience (Pvt) Ltd were  appointed as Manufacturers, while PharmaCo (Pvt) Ltd was appointed  Authorized Distributor (Non-Importer). Kalbe International Pte. Ltd will  officiate as the Non-Trading/Liaison Office/Branch Office and  Healthguard Pharmacy Ltd will operate as Retailer.

The post Prathaban elected President at SLCPI 63rd AGM appeared first on DailyNews.